ASC930 in Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-aGVHD)

NCT04883918 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ASC Therapeutics